Consensus Centene Corporation Xetra

Stocks

QEN

US15135B1017

Managed Healthcare

Market Closed - Xetra 11:35:31 2026-09-30 EDT			After hours 14:30:59
54.60 ^EUR	0.00%		54.55	-0.09%

09-25	Americans navigate 'wild West' of health insurance options after dropping Obamacare plans	RE
09-24	AI tools generated nearly $1 billion in extra costs, Blue Cross insurers say	RE

5ec7b3aa7234dbe5.r685zc_vIlyH-sDW65mDfXrScDOLDsSAl8JChCrHGoM.lvsMt4jYdhvWt_KDndC2MAOmOgO7SJH53u8N6x30X8TbzGCFuL1yJLG9ow~987800a7920552292425d6bf821745fe

Analysts' recommendations: Centene Corporation

09-11	BofA Securities Adjusts Centene Price Target to $80 From $78	MT
08-11	Argus Research Upgrades Centene to Buy From Hold, $80 Price Target	MT
08-04	JPMorgan Adjusts Price Target on Centene to $67 From $60, Maintains Neutral Rating	MT
08-03	Bernstein Adjusts Centene Price Target to $79 From $68, Maintains Outperform Rating	MT
07-29	Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says	MT
07-29	UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating	MT
07-29	Jefferies & Co Adjusts Centene Price Target to $59 From $48, Maintains Hold Rating	MT
07-29	Truist Lifts Price Target on Centene to $80 From $78, Keeps Buy Rating	MT
07-29	Goldman Sachs Adjusts Centene Price Target to $56 From $40, Maintains Sell Rating	MT
07-29	Morgan Stanley Adjusts Centene Price Target to $66 From $57, Maintains Equal Weight Rating	MT
07-29	Baird Adjusts Centene Price Target to $66 From $46, Maintains Neutral Rating	MT
07-29	Deutsche Bank Adjusts Centene Price Target to $85 From $80, Maintains Buy Rating	MT
07-29	Analyst recommendations: Carmax, Kla Corporation, Nasdaq, Fortinet, PayPal…
07-28	Barclays Raises Centene Price Target to $80 From $75	MT
07-14	Truist Raises Price Target on Centene to $78 From $71, Keeps Buy Rating	MT
07-14	TD Cowen Adjusts Price Target on Centene to $65 From $47, Maintains Hold Rating	MT
07-13	Mizuho Adjusts Price Target on Centene to $69 From $63, Maintains Neutral Rating	MT
07-13	Wells Fargo Adjusts Price Target on Centene to $69 From $56, Maintains Equalweight Rating	MT
07-09	RBC Trims Price Target on Centene to $71 From $70, Maintains Sector Perform Rating	MT
07-07	Cantor Fitzgerald Adjusts Centene Price Target to $75 From $60	MT
06-23	Centene's Multi-Year Recovery Underway, RBC Says	MT
06-23	RBC Initiates Centene at Sector Perform With $70 Price Target	MT
06-08	JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating	MT
06-04	UnitedHealth, CVS, Cigna Seen Benefiting From Utilization Trends, AI Upside, Morgan Stanley Says	MT
06-04	Morgan Stanley Raises Price Target on Centene to $57 From $50, Keeps Equalweight Rating	MT

More recommendations

Other Managed Healthcare

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CENTENE CORPORATION	-	-	-	-
UNITEDHEALTH GROUP INC.				+28.48%
ELEVANCE HEALTH, INC.				+14.93%
CIGNA				+24.19%
HUMANA INC.				+9.53%
CENTENE CORPORATION				+15.38%
MOLINA HEALTHCARE, INC.				+10.42%
BRADSAÚDE S.A.				+37.11%
CLOVER HEALTH INVESTMENTS, CORP.				+24.28%
PROGYNY, INC.				+38.83%
Average				+22.57%
Weighted average by Cap.				+23.67%